Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Pediatric Bioscience, Inc. See All Filings	D/A	2015-03-17 00:00:00 UTC
Amount To Be Raised $1,677,288 Associated Brokers / Dealers N/A CIK Number 0001594462 Filed Document 0000897069-15-000231 Exclusions or Exemptions 506b Accepted Date 2015-03-17 00:00:00 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Debt
Pediatric Bioscience, Inc. See All Filings	D	2014-12-15 00:00:00 UTC
Amount To Be Raised $670,921 Associated Brokers / Dealers N/A CIK Number 0001594462 Filed Document 0000897069-14-000492 Exclusions or Exemptions 506b Accepted Date 2014-12-15 00:00:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Debt
Pediatric Bioscience, Inc. See All Filings	D/A	2014-07-15 00:00:00 UTC
Amount To Be Raised $2,000,000 Associated Brokers / Dealers N/A CIK Number 0001594462 Filed Document 0000897069-14-000332 Exclusions or Exemptions 506b Accepted Date 2014-07-15 00:00:00 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
Pediatric Bioscience, Inc. See All Filings	D	2014-01-06 00:00:00 UTC
Amount To Be Raised $2,000,000 Associated Brokers / Dealers N/A CIK Number 0001594462 Filed Document 0000897069-14-000004 Exclusions or Exemptions 506b Accepted Date 2014-01-06 00:00:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
Pediatric Bioscience, Inc. See All Filings	D	2013-12-18 00:00:00 UTC
Amount To Be Raised $2,000,000 Associated Brokers / Dealers N/A CIK Number 0001594462 Filed Document 0000897069-13-000422 Exclusions or Exemptions 506b Accepted Date 2013-12-18 00:00:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity